These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 1375247

  • 1. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.
    Heumann D, Gallay P, Barras C, Zaech P, Ulevitch RJ, Tobias PS, Glauser MP, Baumgartner JD.
    J Immunol; 1992 Jun 01; 148(11):3505-12. PubMed ID: 1375247
    [Abstract] [Full Text] [Related]

  • 2. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaccharide-stimulated human monocytes.
    Couturier C, Jahns G, Kazatchkine MD, Haeffner-Cavaillon N.
    Eur J Immunol; 1992 Jun 01; 22(6):1461-6. PubMed ID: 1376258
    [Abstract] [Full Text] [Related]

  • 3. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
    Leeuwenberg JF, Dentener MA, Buurman WA.
    J Immunol; 1994 May 15; 152(10):5070-6. PubMed ID: 7513728
    [Abstract] [Full Text] [Related]

  • 4. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes.
    Gallay P, Jongeneel CV, Barras C, Burnier M, Baumgartner JD, Glauser MP, Heumann D.
    J Immunol; 1993 Jun 01; 150(11):5086-93. PubMed ID: 7684419
    [Abstract] [Full Text] [Related]

  • 5. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
    Tobias PS, Soldau K, Kline L, Lee JD, Kato K, Martin TP, Ulevitch RJ.
    J Immunol; 1993 Apr 01; 150(7):3011-21. PubMed ID: 7681085
    [Abstract] [Full Text] [Related]

  • 6. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.
    Blondin C, Le Dur A, Cholley B, Caroff M, Haeffner-Cavaillon N.
    Eur J Immunol; 1997 Dec 01; 27(12):3303-9. PubMed ID: 9464818
    [Abstract] [Full Text] [Related]

  • 7. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide.
    Haziot A, Tsuberi BZ, Goyert SM.
    J Immunol; 1993 Jun 15; 150(12):5556-65. PubMed ID: 7685797
    [Abstract] [Full Text] [Related]

  • 8. Moesin: a potential LPS receptor on human monocytes.
    Amar S, Oyaisu K, Li L, Van Dyke T.
    J Endotoxin Res; 2001 Jun 15; 7(4):281-6. PubMed ID: 11717582
    [Abstract] [Full Text] [Related]

  • 9. Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages.
    Landmann R, Ludwig C, Obrist R, Obrecht JP.
    J Cell Biochem; 1991 Dec 15; 47(4):317-29. PubMed ID: 1724447
    [Abstract] [Full Text] [Related]

  • 10. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
    Golenbock DT, Bach RR, Lichenstein H, Juan TS, Tadavarthy A, Moldow CF.
    J Lab Clin Med; 1995 May 15; 125(5):662-71. PubMed ID: 7537790
    [Abstract] [Full Text] [Related]

  • 11. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages.
    Dentener MA, Bazil V, Von Asmuth EJ, Ceska M, Buurman WA.
    J Immunol; 1993 Apr 01; 150(7):2885-91. PubMed ID: 7681082
    [Abstract] [Full Text] [Related]

  • 12. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity.
    Theofan G, Horwitz AH, Williams RE, Liu PS, Chan I, Birr C, Carroll SF, Mészáros K, Parent JB, Kasler H.
    J Immunol; 1994 Apr 01; 152(7):3623-9. PubMed ID: 7511654
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function.
    Grunwald U, Krüger C, Schütt C.
    Circ Shock; 1993 Mar 01; 39(3):220-5. PubMed ID: 7680967
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14.
    Weinstein SL, June CH, DeFranco AL.
    J Immunol; 1993 Oct 01; 151(7):3829-38. PubMed ID: 7690817
    [Abstract] [Full Text] [Related]

  • 20. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
    Troelstra A, de Graaf-Miltenburg LA, van Bommel T, Verhoef J, Van Kessel KP, Van Strijp JA.
    J Immunol; 1999 Apr 01; 162(7):4220-5. PubMed ID: 10201950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.